🇺🇸 FDA
Patent

US 11925685

DNA antibody constructs encoding anti-ZIKV envelope antibodies

granted A61KA61K2039/505A61K2039/53

Quick answer

US patent 11925685 (DNA antibody constructs encoding anti-ZIKV envelope antibodies) held by Inovio Pharmaceuticals, Inc. expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Inovio Pharmaceuticals, Inc.
Grant date
Tue Mar 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2039/505, A61K2039/53, A61K31/7088, A61K39/12